글로벌 동물 항균제 및 항생제 시장 – 2031년까지의 산업 동향 및 예측

동물용 항균제 및 항생제 시장 분석 및 규모

동물용 항균제 및 항생제 시장은 내성을 줄이고 효능을 강화하는 데 중점을 두고 계속 진화하고 있습니다. 진보에는 안전성과 규정 준수를 강조하는 새로운 제형 및 전달 시스템이 포함됩니다. 정밀 번식 및 유전체 도구와 같은 기술은 치료 전략을 변화시키고 있습니다. 성장은 가축 생산 증가와 엄격한 건강 기준에 의해 촉진됩니다. 지속적인 혁신은 글로벌 건강 문제 속에서 지속 가능한 관행을 보장합니다.

글로벌 동물용 항균제 및 항생제 시장 규모는 2023년에 25억 6천만 달러로 평가되었으며, 2031년까지 36억 4천만 달러에 도달할 것으로 예상되며, 2024년부터 2031년까지의 예측 기간 동안 CAGR은 4.50%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화       

Market Definition

Animal antimicrobials and antibiotics refer to medications used in veterinary medicine to treat and prevent bacterial infections in animals. These drugs are crucial for maintaining animal health and welfare in agriculture, companion animals, and wildlife conservation. However, their use requires careful management to prevent antibiotic resistance and ensure food safety. Regulatory frameworks govern their use to promote responsible antibiotic stewardship in animal populations.

Animal Antimicrobials and Antibiotics Market Dynamics

Drivers

• Increasing Demand for Animal Protein

The increasing global demand for animal protein, driven by population growth and dietary shifts towards higher protein intake, fuels the need for antibiotics in livestock. These medications are crucial for preventing and treating diseases, ensuring uninterrupted production of meat, milk, and eggs. For instance, in intensive poultry farming, antibiotics are essential to control infections such as avian influenza, maintaining the health and productivity of large-scale poultry operations worldwide.

• Rising Incidences of Animal Diseases

The rising incidence of infectious diseases in livestock poses significant threats to health and productivity, driving the demand for antibiotics. For example, outbreaks of avian influenza and foot-and-mouth disease necessitate immediate intervention to prevent widespread economic losses in poultry and livestock sectors. Antibiotics play a crucial role in controlling these outbreaks, ensuring animal welfare and sustaining agricultural productivity, thereby driving growth in the animal antimicrobials and antibiotics market.

Opportunities

• Technological Advancements in Veterinary Medicine

Technological advancements in veterinary medicine, such as advanced diagnostic tools and precision treatments, are creating opportunities in the antibiotics and antimicrobials market. For instance, the development of rapid diagnostic tests enables early detection of diseases, facilitating targeted antibiotic use. Additionally, innovations in vaccine development offer preventative solutions, reducing the reliance on antibiotics. These advancements not only improve animal health outcomes but also drive demand for more effective and specialized antimicrobial products.

• Increased Investments in Animal Healthcare

Increased investments in animal healthcare, particularly by pharmaceutical companies and agricultural stakeholders, present significant opportunities in the antibiotics market. These investments fuel research and development efforts aimed at developing new formulations and therapies that enhance animal health outcomes. For instance, collaborations between veterinary experts and pharmaceutical firms have led to innovative antibiotics that effectively combat emerging diseases in livestock, thereby expanding the market's product offerings and capabilities.

Restraints/Challenges

• Concern of Antibiotic Resistance

Increased use of antibiotics in animal agriculture fuels antibiotic-resistant bacteria, posing severe risks through foodborne transmission and undermining antibiotic efficacy in veterinary and human medicine. This threat amplifies public health concerns, limiting treatment options and complicating disease management. Regulatory pressures and consumer awareness drive stringent measures, challenging traditional farming practices reliant on antibiotics. Addressing these issues demands substantial changes in agricultural practices and heightened vigilance in antibiotic stewardship.    

• Complex Supply Chain and Distribution Issues

The complex supply chain and distribution issues in the animal antimicrobials market pose significant challenges. Varied regulatory demands across regions complicate logistics, potentially delaying access to essential products. This logistical complexity and regulatory disparity hinder market efficiency, exacerbating difficulties in ensuring proper distribution and administration of antimicrobials across diverse farming operations.   

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Developments

• In July 2020, Trianni Inc. (USA) and Zoetis (USA) initiated a collaboration aimed at developing transgenic monoclonal antibody platforms to innovate veterinary medications. This partnership seeks to leverage Trianni's expertise in antibody discovery and Zoetis's leadership in animal health solutions. The FDA recently approved Zoetis's acquisition of Marboquin (USA), marking a strategic move to bolster their portfolio and capabilities in the veterinary pharmaceutical sector.

Animal Antimicrobials and Antibiotics Market Scope

The market is segmented on the basis of product type, mode of delivery and animal. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Tetracycline
• Penicillin
• Sulfonamide
• Macrolide
• Cephalosporin
• Fluoroquinolone
• Aminoglycosides
• Lincosamides

 Mode of Delivery

• Premixes
• Oral Powder
• Oral solutions
• Premixes
• Injection

 Animal

• Food-Producing Animals
  • Cattle
  •  Pigs
  •  Poultry
  • Sheep and Goats
  • Other
• Companion Animals
  • Dogs
  •  Cats
  • Horses
  • Other

Animal Antimicrobials and Antibiotics Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, product type, mode of delivery and animal as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

북미는 급증하는 동물 개체 수, 확장되는 반려동물 보험 부문, 동물성 식품에 대한 수요 증가, 동물 건강에 대한 지출 증가로 인해 동물용 항균제 및 항생제 시장을 지배할 것으로 예상됩니다. 이러한 요소들이 모여 이 지역의 수의학 의약품 시장 성장을 견인합니다.

아시아 태평양 지역은 이 지역의 동물 개체 수가 증가하고 동물성 식품에 대한 수요가 증가함에 따라 동물용 항균제 및 항생제 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 이러한 추세는 이 지역의 다양한 경제권에서 동물 건강과 생산성을 보장하기 위한 수의학적 건강 관리 관행에 대한 인식과 채택이 증가하고 있음을 반영합니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 동물용 항균제 및 항생제 시장 점유율 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• Zoetis Services LLC(미국)
• 베링거인겔하임인터내셔널(독일)
• 머크앤코(미국)
•  엘리 릴리 앤드 컴퍼니(미국)
• Bayer AG(독일)
• 데크라 파마슈티컬스 리미티드(영국)
•  비르박(프랑스)
• 베토퀴놀(프랑스)
• 사노피(프랑스)
• 엘란코(미국)
• 엔도백 애니멀 헬스(미국)
• ECO - 애니멀 헬스 유한회사(영국)
• Indian Immunologicals Ltd. (인도)
• Ashish Life Science(인도)
•  Lutim Pharma Private Limited(인도)

SKU-61243